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MutagenesisFifteen mutant dengue viruses were engineered and used to identify AAs in the molecular hinge of the
envelope protein that are critical to viral infection. Substitutions at Q52, A54, or E133 reduced infectivity in
mammalian cells and altered the pH threshold of fusion. Mutations at F193, G266, I270, or G281 affected viral
replication in mammalian and mosquito cells, but only I270W had reduced fusion activity. T280Y affected the
pH threshold for fusion and reduced replication in C6/36 cells. Three different mutations at L135were lethal in
mammalian cells. Among them, L135G abrogated fusion and reduced replication in C6/36 cells, but only
slightly reduced the mosquito infection rate. Conversely, L135W replicated well in C6/36 cells, but had the
lowest mosquito infection rate. Possible interactions between hinge residues 52 and 277, or among 53,
135, 170, 186, 265, and 276 required for hinge function were discovered by sequence analysis to identify
compensatory mutations.nch, Division of Vector-Borne
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Dengue is the most important mosquito-borne viral disease in the
world, with over 2.5 billion people living in more than 100 endemic
countries at risk.Up to100million infectionsoccur annuallywith500,000
cases of severe dengue hemorrhagic fever/dengue shock syndrome, and
22,000 deaths,mainly among children (http://www.who.int/csr/disease/
dengue/impact). Dengue viruses (DENVs) are transmitted by Aedes spp.
mosquitoes, principally Ae. aegypti, and there are 4 distinct serotypes
(types 1–4; DENV1–4)within the DENV serocomplex of genus Flavivirus,
family Flaviviridae. The mature ﬂavivirus is approximately 500 Å in
diameter and has a capsid (C) protein core complexed with a single-
stranded positive-sense RNA genome (~11 kb). The core is surrounded
by a lipid bilayer in which 180 copies each of the viral envelope (E)
protein and membrane (M) protein are embedded. The E proteins are
arranged in an icosahedral scaffold of 90homodimers that are complexed
with the M protein (Kuhn et al., 2002). The E protein is a class II fusion
protein, essential for host cell attachment, entry, viral-endosome
membrane fusion, and virus assembly.Following attachment, the virion is internalized mainly via
receptor-mediated, clathrin-dependent endocytosis (Chu and Ng,
2004; Gollins and Porterﬁeld, 1985; Mosso et al., 2008; van der Schaar
et al., 2008). The lower pH in the endosomes triggers an oligomeric
rearrangement of the E protein from homodimers to homotrimers
(Bressanelli et al., 2004;Modis et al., 2004; Stiasny et al., 2004). During
the rearrangement, pre-fusion E dimers dissociate to intermediate
monomers with exposed fusion peptides (FPs) that can interact with
endosome membranes. Subsequently, the E monomers form post-
fusion homotrimers, bringing into contact the C-terminal membrane
anchor of the E protein with the FP-inserted endosome membrane
(Stiasny et al., 2007). After membrane fusion, viral nucleocapsid
escapes from the endosome and initiates viral replication.
Solved structures of the soluble ﬂavivirus E protein ectodomain
crystals revealed three domains (DI, DII, and DIII) (Modis et al., 2003,
2005; Rey et al., 1995), which correlate to the previously deﬁned
antigenic domains C, A, and B (Heinz, 1986; Mandl et al., 1989; Roehrig
et al., 1990). DIII is connected to DI by a single peptide strand. DI and DII
are linearly discontinuous structures connected by four peptide strands
that function as a “molecular hinge (H)” during low pH-induced E
protein reorganization to facilitate viral fusion with endosomal
membranes (Rey et al., 1995). The four loosely packed DI-DII interface
peptides, designated H-1 to H4 (Hurrelbrink and McMinn, 2001),
provide ﬂexibility for the low-pH catalyzed E conformational changes.
Further evidence of the hinge role included mutations at this region
affecting viral virulence and/or the pH threshold for fusion (Cecilia and
119S. Butrapet et al. / Virology 413 (2011) 118–127Gould, 1991; Hurrelbrink and McMinn, 2001; Lee et al., 1997; Monath
et al., 2002), aswell as the change in orientation between theDENVpre-
fusion and post-fusion crystal structures (Modis et al., 2003, 2004).
Comparison between the crystal structures of the E monomers of
mature and immature virionsdemonstrated a rotation around thehinge
region, suggesting the hinge motions are also essential for the virus
maturation process (Zhang et al., 2004). In addition, a stemconsisting of
two α-helices that links the soluble ectodomain and trans-membrane
domain of the E protein is likely to contribute further ﬂexibility required
for the conformational change (Zhang et al., 2003).
Recently, we reported detailed mutagenesis studies of the DENV2
E protein DII FP (Huang et al., 2010) and DIII FG loop (Erb et al., 2010).
In this report, we identiﬁed AAswithin the hinge region of DENV2 that
are critical for viral replication and fusion. We engineered 15 DENV2
mutants by introducing distinct mutations at two residues each in H-1
to H-3 and at 5 residues in H4 into cDNA infectious clones. Through
analysis of the mutation effects on growth in cell cultures and AedesA
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antibodies (MAbs), we identiﬁed nine residues within the E protein H
peptides that are important for DENV2 replication.
Results
Design and construction of mutant viruses
Our mutagenesis targets were designed to determine the impor-
tance of highly conserved AA residues, the side-chain size of these
residues, and the biochemical properties of the residues in maintain-
ing the function of the E protein molecular hinge. Identiﬁcation of AAs
within the DENV2 H region (Fig. 1), H-1: AA 51–54 (E residues), H-2:
AA 130–135, H-3: AA 186–196, and H4: AA 265–283, was based on the
DENV2 E protein crystal structure (Modis et al., 2003). The 4 hinge
peptides exhibit different levels of homology among ﬂavivirusesA54
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Table 1
Amino acid sequence alignment of E protein hinge region peptides among ﬂaviviruses.
Virusa H-1(E51-54)b H-2 (E130-135)b H-3(E186-196)b
DENV2 16681 K Q P A V Q P E N L S P R T G L D F N E M
DENV1 16007 T N • • • • Y • • • • • • • • • • • • • •
DENV3 16562 T • L • • • H • • • • • • • • • • • • • •
DENV4 1036 • E V • • • I • • • E • • S • I • • • • •
JEV JaOArS982 S • L • I • • • • I E • • S • • N T E A F
WNV NY99 A N L • I L K • • I E • • S • I • T • A Y
MVEV T N L • I L • • D I E • • S • • N T E A Y
SLEV MSI7 T E L • I L R • • I E A • S • I N T E D Y
YFV Asibi D G • • • D Q T K I Q V Q • A V • • G N S
TBEV Neudoerﬂ E N • • Y D A N K I R V A S • V • L A Q T
LGTV TP21 E S • • Y D V N K I R V A S • V • L A Q T
POWV LB E S • • Y D S T K I R V A S • I • V A Q T
Virus H-4 (E265-283)b
DENV2 16681 T G A T E I Q M S S G N L – – – L F T – G H L
DENV1 16007 • • • • • • • T • G T T T – – – I • A – • • •
DENV3 16562 • • • • • • • T • G G T S – – – I • A – • • •
DENV4 1036 A • • • • V D S G D G • H – – – M • A – • • •
JEV JaOArS982 A • • I V V E Y • • S – V – – – K L • S • • •
WNV NY99 A • • I P V E F • • N T V – – – K L • S • • •
MVEV A • • I P V E F • • S T • – – – K L • S • • •
SLEV MSI7 A • • I P A T V • • S T • – – – T L Q S • • •
YFV Asibi T • • M R V T K D T N D N N L Y K L H G • • V
TBEV Neudoerﬂ A • – – – V P V A H I E G T K Y H L K S • • V
LGTV TP21 A • – – – V P V A • I E G T K Y H L K S • • V
POWV LB A • – – – V P L A • V E G Q K Y H L K S • • V
a Assesion numbers: U87411 (DENV2), AF180818 (DENV1), M18370 (JEV), AF196835 (WNV: West Nile virus), X03467 (MVEV: Murray Valley encephalitis virus), AY289618
(SLEV: St. Louis encephalitis virus), AY640589 (YFV), U27495 (TBEV: tick-borne encephalitis virus), AF253419 (LGTV: Langat virus), L06436 (POWV: Powassan virus).
b AA positions of DENV2 E protein. Bold letters: Target DENV2 AA for mutations. Alignment: •, AA is the same as DENV2; –, no AA.
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hydrophobic residues at 53–54. We made a mutation at Q52 to R,
which has been speculated to be involved in mouse attenuation in
conjunction with other mutations in yellow fever virus (YFV) 17D
vaccine (Schlesinger et al., 1996) and a Japanese encephalitis virus
(JEV) mutant (Hasegawa et al., 1992). The A54, located near the N-
terminus of a DII β-sheet, is highly conserved among ﬂaviviruses
(Table 1), andwe substituted the small hydrophobic residuewith a large
acidic residue (A54E) to investigate the importance of this conservation.
Mutationof thewild-type (wt)YFVFrenchviscerotropic virus (FVV)A54
to V in the Frenchneurotropic vaccine (FNV)was postulated to be oneof
the E protein mutations contributing to the attenuation phenotype of
FNV (Ni et al., 2000;Wang et al., 1995). InH-2, E133 is conserved among
the mosquito-borne ﬂaviviruses and residue 135 (L or I) is highly
conserved among all ﬂaviviruses. We made a charge change from an
acidic E to a basic K for residue 133 and for L135,mutations toW (larger
hydrophobic), G (no side chain), or K (basic) were generated to
investigate the effect of size and hydrophobicity on this AA. In H-3, we
changed the highly conserved G190 to much larger side-chain F or W.
Wealso targeted the largehydrophobic F193 that is conserved among all
four serotypes of DENV and changed it to a smaller hydrophobic A or a
basic R. DENV3 containing a mutation at this residue showed a marked
decrease in fusion pH threshold (Lee et al., 1997). H4 contains highly
variable AAprimary sequences among theﬂaviviruses, and is the longest
linker of the hinge region. We substituted the conserved G266, I270, or
G281 to the larger W in each case. The F279 is conserved among the
DENVs and a F277S mutation in DENV3 (equivalent to F279 in DENV2)
has been shown to decrease the fusion pH threshold. We changed F279
to a smaller A in our study. A semi-conserved small residue, T280, was
also targeted for a substitution with a much larger Y.Viability of the mutant viruses
All 15 hingemutations resulted in viable mutant viruses recovered
from transfected Vero and/or C6/36 cells, with working seed titers
ranging from 5.03 to 7.95 log10 TCID50/ml (measured in C6/36 cells).Full-genome sequences of all recovered working seeds were deter-
mined, and only the viruses with accurate genome sequences were
used for subsequent phenotypic characterizations. In Vero cells, eight
mutants, including two lethal (no virus recovered after multiple
transfection efforts) and six unstable mutants (virus recovered with
reversion and/or extra non-synonymous mutation), were considered
nonviable (Table 2). Interestingly, virus recovered from the L135K
mutation acquired a substitution that changed the engineered K to M.
Mutants E133K, L135W, and G266W showed reversion at the
mutation site in the recovered virus seeds. Mutant I270W retained
the correct mutation, but acquired additional mutations at K64M and
K122I. The extra K122I mutation was also found in revertants of
mutants E133K and G266W. In fact, the additional K122I or K122E
mutations were identiﬁed in other mutants we reported previously
(Erb et al., 2010) as well as in several wt DENV2 16681 seeds passaged
in Vero cells (unpublished data). In contrast, all the eight nonviable
mutants in Vero cells produced infectious viruses from C6/36 cells
with expected full-length genome sequences.Growth kinetics of the mutant viruses
Growth kinetics of the mutant viruses were analyzed in Vero,
HepG2, K562, andC6/36 cells for 12–14 days bymeasuring viral RNA in
culture medium by qRT-PCR. Since some mutant viruses did not
replicate or produce plaques in Vero cells, infectious virus titer in
growth medium at the peak day of viral RNA release for each mutant
was measured by 50% tissue culture infectious dose (TCID50) assay in
C6/36 cells. Allmutant viruses replicated similarly towt 30P-NBXvirus
(clone-derived DENV2 16681) in C6/36 cells, with exponential RNA
increase between day 0 and day 6, and reached plateau titers around
10–11 log10 copies/ml between day 6 and day 14 (data not shown).
However, the infectious virus titers measured at the peak viral RNA
time points were lower than parental virus for seven mutant viruses,
L135G, L135K, F193R, G266W, I270W, T280Y, and G281W (Fig 2A).
In Vero cells, growth kinetics of mutants G190F, G190W, F279A
and T280Y were similar to control 30P-NBX virus (Fig. 2B). Mutants
Table 2
Viability, genome sequence, and fusion capacity of the clone-derived hinge region mutant viruses.
Virus Vero cells C6/36 cells Fusion
Viabilitya Sequenceb Viabilitya Sequenceb Activity at pH 5.5c pH Threshold
30P-NBX + Correct + Correct 1±0.15 6.3–6.5
Q52R + Correct nd na 1.06±0.29 6.5–6.8
A54E + Correct nd na 1.02±0.24 ≥6.8
E133K − Rev+K122I + Correct 1.14±0.03 ≥6.8
L135W − Rev + Correct 1.23±0.22* ≥6.8
L135G − No virus + Correct 0.05±0.07** −
L135K − L135M + Correct 0.95±0.05 6.3–6.5
G190F + Correct nd na 1.10±0.03 6.3–6.5
G190W + Correct nd na 1.01±0.10 ≥6.8
F193A + Correct nd na 1.27±0.23* 6.5–6.8
F193R − F193L/R + Correct 1.06±0.02 6.3–6.5
G266W − Rev+K122I + Correct 0.90±0.20 6.3–6.5
I270W ± + K64M+K122I + Correct 1.02±0.08 6.0–6.3
F279A + Correct + Correct 0.86±0.22 6.3–6.5
T280Y + Correct nd na 0.77±0.11* 6.0–6.3
G281W − No virus + Correct 1.10±0.19 6.3–6.5
a Viability: + virus recovered from transfected cells.− Either no virus recovered or recovered virus had reversion or mutations at the target site. ± recovered virus had correct
mutation at target site, but acquired additional E mutations. nd: not done.
b Full-length genome sequence of clone-derived viruses: correct genome sequence (correct), reverted to wt (Rev), recovered with different substitution at the mutation site
(shown), or contained the engineered mutation plus substitution(s) at different E protein residue(s) (shown as +). There were no mutations in other genes. na: not applicable.
c Fusion activity (±standard deviation) normalized to clone-derived wt D2-30P-NBX virus at pH 5.5 (calibrated fusion index of wt control in each experiment=1); standard
deviation for wt was calculated from all wt controls included in experiments. Student's t-test *pb0.05, **pb0.0005.
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the control virus. Mutant Q52R also replicated similarly to thewt virus
up to day 8, but the titers dropped on day 10. Both growth curve
cultures of Q52R showed signiﬁcantly more cytopathic effects (CPE)
than the wt and other mutant viruses on day 8–12, suggesting the
decreased virus titers after day 10 may be the result of signiﬁcant cell
death. Most of these viruses were viable and seemed to be genetically
stable in Vero cells after 2 passages (Table 2), but we found that at day
12 of the growth curve, virus released by mutant Q52R had acquired
two additional partial mutations (mixed consensus sequences
detected), K122I/K and L277L/S. Notably, AA 277 is close to AA 52 in
the E protein crystal structure (Fig. 1C). This suggests that the Q52R
mutation affected replication in Vero cells, even though it was not
easily detected by growth kinetics at early stages, leading to
accumulation of compensatory and cell-adaptive mutations that
enhanced viral replication. It is likely the replication enhancement
also led to greater CPE in the cells, resulting in signiﬁcantly decreased
viral genomic titers at later time points.
Interestingly, mutant L135G failed to replicate in Vero cells, and
the remaining seven mutant viruses showed signiﬁcant delays in viral
replication for 4–6 days (Fig. 2C). The seven mutants with delayed
replication eventually broke through after day 6, and genome
sequence analysis of the day 12 samples from these growth curves
revealed that two mutants, G266W, and G281W, had almost fully
reverted to the wt sequence. The mutant E133K sample harvested on
day12 revealed mixed sequences at the engineered mutation site,
with either wt reversion or 133Q substitution. The day 12 sample of
mutant L135W had not reverted to wt as previously found in Vero
cell-derived virus (Table 2), but had acquired two additional
mutations in or near the hinge region, P53L/P (mixed sequence
population) and T170A (Fig. 1D). The day 12 sample of mutant I270W
had the same additional mutations (K64M/K and K122I/K) that were
found in the Vero cell-derived I270W mutant virus seed (Table 2).
Similarly, the L135K and F193R mutants evolved to L135M and F193L,
respectively, during the growth curve study, which is consistent with
the changes observed in deriving these mutants from Vero cells
(Table 2). In addition to the evolved L135M mutation, the day 12
sample of L135K revealed mutation T265T/S, located at the end of H-4
(Fig. 1D).
To further investigate the growth kinetics of themutants in different
mammalian cell types, we conducted growth curve studies in HepG2and K562 cells. Both HepG2 cells (hepatocytes) and K562 cells
(leukemia cells) were human cells that are highly susceptible to DENV
infection and have beenwidely used in study of DENV infection. Growth
curves in HepG2 and K562 showed similar results as in Vero cells (data
not shown). The control 30P-NBX virus replicated to peak titers of 6–7
log10 TCID50/ml in these cells. Mutation L135G was lethal in all
mammalian cells tested. Mutants that showed suboptimal or delayed
replication in Vero cells also grew poorly in HepG2 and K562 cells. In
fact, many of the mutant viruses did not replicate to sufﬁcient titers in
HepG2 cells for genome sequencing. Partial or full reversion and/or
unexpected substitutions identiﬁed in theVero cell day 12growth curve
samples of mutants E133K, L135K, F193A, G266W, and G281W were
also found in the day 12 samples of the K562 cell growth kinetics study.
Although the day 12 Vero cell growth curve sample of mutant Q52R
showed extra mutations, the mutant maintained correct genome
sequence in K562 and HepG2 cells. Interestingly, mutant L135W
grown in K562 cells evolved additional mutations S186F/S and
N276N/Y, which were different from those identiﬁed in the Vero cell
day 12 sample. However, these twomutations alsomapped to the hinge
region (Fig. 1D), suggesting they may be compensatory mutations.Temperature sensitivity of the hinge mutants
To determine whether the different incubation temperatures for
mammalian cells (37 °C) and C6/36 cells (28 °C) contributed to the
radical difference in the viability and genetic stability of eight mutant
viruses, E133K, L135G, L135W, L135K, F193R, G266W, I270W, and
G281W, we examined growth kinetics of these mutants in Vero cells
at 28 °C (data not shown). Except for mutant L135G, all mutants and
the wt 30P-NBX viruses replicated slower and reached lower peak
titers at 28 °C compared to their growth at 37 °C. Genomic sequences
of the 28 °C day 12 samples of Q52R, E133K, and I270W revealed
similar extra mutations or wt reversion to those observed in the 37 °C
growth curve study, indicating that the lower temperature did not
abrogate the instability of these mutants in Vero cells. Although extra
substitutions or reversion were not found at day 12 in the 28 °C
samples of mutants L135W, L135K, F193R, G266W, and G281W, we
cannot rule out the possibility that cell-adaptation mutations or
reversions were present but not yet detectable because of their very
low titers.
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122 S. Butrapet et al. / Virology 413 (2011) 118–127Interestingly, the L135G virus that was nonviable at 37 °C was able
to replicate in Vero cells at 28 °C. It reached titers about 10-fold lower
than the wt virus, and no evidence of extra E-gene mutations was
found after 12 days’ growth at 28 °C. It appeared that the L135G
substitution signiﬁcantly decreased viral thermal stability at 37 °C. To
further investigate the profound effect of the L135G mutation on viral
thermal stability, we conducted temperature shift experiments in
Vero cells to analyze the temperature effect at different stages of the
virus replication. As expected, shift of the wt virus-infected culture to
37 °C after 28 °C adsorption signiﬁcantly enhanced virus replication
(Fig. 3A), while temperature shift to 28 °C after 37 °C adsorption
caused slower virus replication (Fig. 3C). In contrast, temperature
shift to 37 °C after adsorption at 28 °C signiﬁcantly abrogated mutant
L135G replication (Fig. 3A), while shift of the temperature to 28 °C
after adsorption at 37 °C resulted in restoration of L135G virus
replication in Vero cells (Fig. 3C). Measurement of intracellular
negative-strand viral RNA of mutant L135G showed an increase
within 48 h after infection in all temperature combinations (Fig. 3B
and D). However, after 48 h the amount of negative-strand RNA in the
L135G-infected cells that were maintained at or shifted to 37 °C
dropped to a lower level than those cultures maintained at or shifted
to 28 °C (Fig. 3B and D). These results indicated that mutant L135Gwas competent in cell attachment/entry and initiation of viral RNA
replication in Vero cells at either temperature, but its thermal
instability at 37 °C affected later stages of virus replication. Since the
titers of L135G were 10-fold less than wt virus, even when grown at
28 °C, decreased thermal stability may only be part of the cause of its
replication deﬁciency in Vero cells.
Replication of the mutants in Aedes aegypti mosquitoes
Although all the mutant viruses replicated reasonably well in
mosquito C6/36 cells, it is important to assess their infectivity in intact
Ae. aegypti mosquitoes to understand the importance of E protein
hinge function in infection of and transmission by the vector. We
chose the three mutants targeted at L135 for mosquito inoculation,
because this set includes mutant L135W, with replication comparable
to wt 30P-NBX, and twomutants, L135G and L135K, that replicated to
signiﬁcantly lower titers in our C6/36 cell growth curve study
(Fig. 2A). We also included mutant L135M, which was recovered
from Vero cells when we were attempting to derive L135K (evolved
from 135K to 135M), to determine whether the Vero cell-adaptation
substitution would increase the virus ﬁtness in mosquitoes. Interest-
ingly, the most C6/36 cell-compatible L135W virus had the lowest
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(L135G: 28 and 30P-NBX: 28) while a duplicate set was moved to 37 °C (L135G: 28/37
and 30P-NBX: 28/37) for 7 days. Bottom panels (C) and (D): Virus adsorption at 37 °C
for 2 h, a set of cultures was then maintained at 37 °C (L135G:37 and 30P-NBX: 37)
while a duplicate set was moved to 28 °C (L135G: 37/28 and 30P-NBX: 37/28). (A) and
(C) show measurement of viral RNA in cell culture medium. (B) and (D) show
measurement of intracellular negative-strand viral RNA.
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inoculation. The infection rate of mutant L135K was also signiﬁcantly
(p=0.017) less than the wt virus, while the Vero cell-adaptedmutant
L135M had a similar infection rate to the wt virus in mosquitoes.
There also was a difference between the mosquito infection rates of
wt virus andmutant L135G (p=0.05), which did not replicate in Vero
cells and replicated most poorly of all mutants in C6/36 cells.
However, because the fusion-incompetent L135G was still able to
infect 74.75% of mosquitoes, we examined its E-gene sequence after
replication inmosquitoes and conﬁrmed that the L135Gmutationwas
retained without other compensatory E mutations.Table 3
Infectivity of the L135 mutant viruses for Ae. aegypti RexD mosquitoes.
Infection rate (%) Total numbers
Virus Average SD Mosquitoes Experiments p⁎
30P-NBX 95.01 4.12 143 5
L135W 11.83 9.57 162 5 b0.0001
L135G 74.75 12.87 98 3 0.052
L135K 81.65 5.73 89 3 0.017
L135M 92.59 12.83 94 3 0.389
⁎ Probability value in Student's t-test (two-tailed, unpaired, unequal variance)
comparing the mutants to wt 30P-NBX.Fusion efﬁciency of the mutants
Fusion-from-within (FFWI) assays in C6/36 cells were conducted
over a range between pH6.0 and pH6.8 to assess the effect of the hinge
mutations in virus-mediated cell membrane fusion. All mutants
replicated reasonably well in C6/36 cells after infection at MOI of
0.001 (Fig. 2A), indicating that this cell line is suitable for the FFWI
assay. To further ensure that the assay was conducted when sufﬁcient
E proteins were expressed by each mutant, cells were infected with a
higher MOI (0.1; 100×-fold higher than for growth curves) and
incubated for 7 days before the FFWI assay. Table 2 lists the fusion
activity normalized to wt fusion at pH5.5 and the pH threshold
range for each mutant. Fig. 4 shows examples of the ﬁve patterns of
fusion curves we observed, including a previously reported fusion-
defective mutant, G104S, containing a mutation in the fusion loop
(Huang et al., 2010) as a negative control. Pattern 1, fusion pH
threshold at pH 6.3–6.5 (similar curve as wt virus), includes L135K,
G190F, F193R, G266W, F279A, and G281W. Pattern 2, slightly lower
fusion pH threshold (pH 6.0–6.3) than wt virus, includes I270W and
T280Y. Pattern 3, slightly higher fusion pH threshold (pH 6.5–6.8)
than wt virus, includes Q52 and F193A. Pattern 4, fusion pH threshold
≥pH 6.8, includes A54E, E133K, L135W, and G190W. Pattern 5, fusion
defective at all pH, is characteristic of only mutant L135G.
Antibody epitopes of the mutant viruses
Apanel ofwell characterizedmurineMAbswasused to analyze the E
protein epitopes of hinge mutants expressed in C6/36 cells at 28 °C.
Most mutants showed similar reactivity to all the testedMAbs as thewt
E protein (data not shown). Substitution of the L135 residuewith K or G
reduced the E protein reactivity with the DI MAb 1B4C-2, by 3-fold
(L135K)or 4-fold (L135G). Changing L135 to eitherWorMhadnoeffect
on 1B4C-2 reactivity. H-4mutations at either G266 or F279 reduced the
reactivity of the DII MAb 2H3 (A4 epitope) by 3-fold. The F193R
mutation reduced the reactivity of the DIII MAb 9A3D-8 (B2 epitope)
by 3-fold.
To further investigate the effect of the temperature sensitivity
mutation L135G on the expression of E protein epitopes, we com-
pared the MAb reactivity with the mutant E protein expressed in Vero
cells at 28 and 37 °C. Signiﬁcantly reduced reactivity to MAbs that
recognize A1, A4, A5, B2, or C1 epitopes, located in all three E domains
(Table 4), was observed formutant L135G-infected cells at 37 °Cwhen
compared to the reactivity of 28 °C infected cells. On the other hand,
the wt viral E protein expressed in 28 °C and 37 °C did not show
signiﬁcant difference in its reactivitywith any of the testedMAbs (data
not shown).
Discussion
The H region of the ﬂavivirus E protein consists of 4 loosely packed
peptide linkers between the DI-D0E0 and DII-gfea β-sheets (Fig. 1B).
This region and its nearby loop structures are highly susceptible to
adaptive mutations during passage in cultured cells and mouse brains
(Bray et al., 1998; Duarte dos Santos et al., 2000; Hasegawa et al.,
1992; Lee et al., 1997; McMinn et al., 1995b; Monath et al., 2002;
Schlesinger et al., 1996) or under selection pressure for neutralization-
resistance (Beasley and Aaskov, 2001; Cecilia and Gould, 1991;McMinn
et al., 1995a; Morita et al., 2001). Viruses with mutations at or near the
hinge region frequently exhibit altered cultured cell infectivity ormouse
virulence compared to their parental viruses; however, some of the
previously studied mutant viruses contained additional mutations in
other regions of the E protein, which made it difﬁcult to fully elucidate
the effect of the hinge mutations (Bray et al., 1998; Chambers and
Nickells, 2001; Duarte dos Santos et al., 2000; Hasegawa et al., 1992; Lee
et al., 1997;Ni et al., 2000). Only a fewhingemutations in JEV, DENV3, or
MVEV have been demonstrated to individually affect virus phenotypes
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1997; Monath et al., 2002). In this study, using well deﬁned mutant
viruses derived from an infectious cDNA clone, wewere able to identify
nine new molecular determinants within the hinge region that can
individually affect DENV2 infection in mammalian and mosquito cell
cultures and in Aedes aegyptimosquitoes.
A Q52R mutation of JEV, combined with additional E protein
mutations, was found to alter the structure of a neutralizing antibody
epitope (Morita et al., 2001), early virus–cell interactions, and mouse
virulence (Hasegawa et al., 1992). Interestingly, a G52R substitution is
one of the mutations in the YFV 17D vaccine, and its neuroadapted
variantswith increasedmouse virulencehadmultiplewtYFVreversions
that included G52 (Chambers and Nickells, 2001). However, study of an
intertypic recombinant virus showed that multiple reversions in E
(including G52) and NS1 could not reconstitute the neurovirulence of
the parental virus (Schlesinger et al., 1996). Our DENV2 Q52Rmutation
caused a shift of the fusion pH threshold to slightly higher than wt, and
increased Vero cell-adaptation pressure that resulted in possibleTable 4
Monoclonal antibody reactivity of mutant L135G-infected Vero cells grown at 37 or 28 °C.
Antibody reactivity (Ab dilution fold at endpoint)⁎
MAb D2-NGC 1B4C-2 4G2 6B6C-1
Epitope poly C1 A1 A1
37 °C 5120 10 20 b10
28 °C 10240 40 2560 640
⁎ Antibody reactivity measured by IFA. Bold ﬁgures indicate greater than 4-fold difference
cells grown at 37 or 28 °C.compensatory mutations at I277 (on H-4) and K122 (DII). The Q52
and I227 residues are very close to eachother in the E protein pre-fusion
dimer structure (Fig. 1C), and their side chains almost face each other in
the monomers of the post-fusion trimer structure (data not shown).
However, the mutation has no signiﬁcant effect in infectivity for C6/36
cells or epitope structures recognized bymultipleMAbs. Q52maynot be
amajormolecular determinant in the hinge region for DENV2 infection,
but mutation at this locus could decrease the stability of the hinge
structure and cause a lower energy requirement (higher pH) for
membrane fusion. Substitution of A54, conserved amongallﬂaviviruses,
to a large acidic AA (E) shifted the fusion threshold to a higher pH and
caused slightly delayed replication in Vero cells, suggesting A54 may
also be important for stabilization of the functional hinge structure.
Interestingly, in contrast to our observation, a DENV3 A54Emutant was
previously shown to shift the fusion threshold to a slightly lower pH
(decrease of 0.2 unit) (Lee et al., 1997). The difference in results may be
due to the signiﬁcant difference of the fusion pH threshold of parental
virus between the two studies. The parental DENV3 used in the study of2H3 1B7-5 3H5 9A3D-8 1A1D-2
A4 A5 B1 B2 B4
40 20 1280 40 640
640 1280 2560 640 1280
from 28 °C cultures. There is no difference in the MAb reactivity with wt virus-infected
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higher than the fusion pH threshold of ourwt DENV2 30P-NBX (pH 6.3–
6.5). Mutation of A54V combined with other mutations in the YFV
vaccine strain FNV, may also be responsible for the diminishing of its wt
viscerotropic phenotype (Ni et al., 2000).
Mutations targeting the H-2 strand mosquito-borne ﬂavivirus-
conserved E133 and ﬂavivirus-conserved L135 caused detrimental
effects in virus infection of Vero cells. Mutation E133K was lethal in
Vero cells and reverted to wt, and the C6/36 cell-derived E133K had a
fusion pH threshold close to neutral pH. It is not surprising that
substitution of conserved E133 (E side chain, pKa=4.25) with an
oppositely charged residue (K, pKa=10.79) would signiﬁcantly alter
the fusion pH threshold. Unlike the results seen in Vero cells, the
drastic change of the mosquito-borne ﬂavivirus-conserved E133 to K
did not affect its viability and replication efﬁciency in C6/36 cells,
suggesting that the intracellular environment of Vero cells required a
different mechanism for virus-mediated endosomal membrane fusion
and/or viral maturation than the C6/36 cells. Such difference could
explain why C6/36 cells were more susceptible than Vero cells to
infection by most of our engineered DENV2 H mutants. This
observation is consistent with our previous reports of other DENV2
mutants (Erb et al., 2010; Huang et al., 2010) and the general
observation that wt DENVs usually replicate to much higher titers in
C6/36 cells than in Vero or other mammalian cells.
The three L135 mutants had various phenotypic characteristics,
and were quite different from the wt virus. The L135W virus could not
replicate well in Vero cells until it reverted to wt or acquired
compensatory mutations at other nearby hinge region residues. The
large side chain of tryptophan likely decreased the stability of the
hinge structure and resulted in a fusion pH threshold shift to more
neutral pH. Although themutant replicatedwell in C6/36 cells, it had a
very low mosquito infection rate compared to wt virus. This supports
our previous observations that infectivity of DENV for C6/36 mosquito
cell cultures may not be an accurate model for predicting viral
infectivity in whole mosquitoes (Erb et al., 2010; Huang et al., 2010).
Changing L135 to K had no signiﬁcant effect on fusion pH threshold;
however, the virus replicated less efﬁciently in C6/36 cells than wt
virus and evolved to 135M or acquired compensatory mutations in
mammalian cells. Although L135K had a higher mosquito infection
rate than mutant L135W, the infection rate was signiﬁcantly lower
than wt virus. Its evolution to 135M during passage of L135K in Vero
cells (designated mutant L135M in Table 3) actually reconstituted the
mosquito infectivity to that of wt virus. L135G was the most
detrimental mutation tested among all the hinge mutations. The
dramatic decrease in size of the AA side chain may have distressed the
hydrophobic pocket structure lined bymultiple hinge residues (Modis
et al., 2003), and resulted in interrupting hinge functions for virus
fusion and/or maturation. Indeed, the mutant failed to mediate
membrane fusion over the entire pH range we tested in the FFWI
assay. Our temperature shift assays and epitope mapping at 28 and
37 °C further support the notion that the 135G mutation altered the
thermal stability of the E protein structures signiﬁcantly at 37 °C.
Interestingly, while exhibiting the most defective infectivity and
fusion capacity in vitro, mutant L135Gwas able to infect Ae. aegypti by
IT inoculation at a rate only slightly less than wt virus. This was not
totally unexpected, considering that mosquitoes are incubated at
28 °C, where mutant L135G was more likely to maintain E protein
structures required for productive mosquito tissue infection. The
highly conserved L (or I) at position135 of all ﬂaviviruses is likely an
evolutionary result of their adaptation to both vertebrate hosts and
arthropod vectors. In addition to determining that L135 is an
important molecular determinant for DENV2 E protein hinge function
and virus infectivity, we also identiﬁed possible interactions between
hinge residues during the E protein conformational change and
rearrangement by mapping the compensatory mutations that evolved
during growth of mutants L135W and L135K in Vero and K562cells (Fig. 1C). The possible interactions include AA residues 135 with
53 and/or 170, 135 with 186 and/or 276, and 135 with 265 (Fig. 1D).
The interactions are likely physical, such as side-chain ﬁt in the protein
folding process, but there could also be chemical interactions, such as
establishing H-bonds during refolding. Due to limited amounts of growth
curve samples, we were not able to further characterize to what extent
those compensatory mutations can restore the virus to wt phenotype.
Future studies using genetically engineered mutants encoding these
compensatory mutations will be necessary to fully elucidate the inter-
actions of theses residues.
Although highly conserved among ﬂaviviruses, H-3 G190 substitu-
tionwith F orWdidnot affectmutant virus replication inmammalian or
mosquito cell cultures. Mutant G190F maintained a similar fusion pH
threshold, but the threshold for G190W shifted to a higher pH,
suggesting that the bulkier W may reduce the stability of the hinge
structure, resulting in requirement of less energy to initiate fusion.
However, this position, residing close to the viral membrane at the pre-
fusion stage (Fig. 1B), appears to be highly tolerant to substitutions of
much larger residues. Switching large hydrophobic side chain F193 to a
smaller A also did not signiﬁcantly alter mutant replication in various
cells. However, change of F193 to hydrophilic R signiﬁcantly delayed
virus replication in Vero cells until the engineered 193R populationwas
partially replaced by 193L. A previous study of DENV3 discovered that
mutation of F191 (DENV3 191 aligns with DENV2 193) to V or L occurs
after multiple passages in Vero cells (Lee et al., 1997). It appears that a
hydrophobic residue is required for residue 193, which lines the
hydrophobic pocket (Modis et al., 2003).
Within the H-4 strand, we identiﬁed G266, I270, and G281as
important molecular determinants for DENV2 replication in both
mammalian and C6/36 cells. Although they are all fusion competent
and only I270W showed a slight shift of the fusion pH threshold, these
mutants did not replicate efﬁciently unless reversions or extra
mutations were evolved in Vero cells. They also replicated to lower
titers than wt virus in C6/36 cells. A somewhat different mutation,
I270S, in aMAb neutralization-resistant JEV has been demonstrated to
be a mouse attenuation determinant (Cecilia and Gould, 1991).
Substitution of T280Y shifted the fusion threshold to a slightly lower
pH and themutant showed signiﬁcantly lower fusion capacity thanwt
virus over the entire pH range. Unlike most other mutants in this
study, mutant T280Y replicated less efﬁciently than wt virus in C6/36
cells, whereas it replicated similarly to wt virus in Vero cells. F279 is
conserved among all DENVs, and a DENV3 F277S mutation (DENV3
AA277 aligns with DENV2 AA279) has been shown to signiﬁcantly
shift the fusion pH threshold in a FFWI assay (Lee et al., 1997).
However, our DENV2 F279A mutation had no signiﬁcant effect on the
fusion pH threshold or virus infection in any of the cells we tested.
Since F279 also participates in the hinge hydrophobic pocket
structure, the residue likely requires a hydrophobic side chain such
as F and A. Therefore, it is not surprising thatmutation to hydrophilic S
could alter the virus characteristics.
Epitope mapping of cells infected with these mutants identiﬁed
mutations that altered MAb reactivity with all three E protein
domains. The observation that changes at AA 135 altered MAb
1B4C-2 reactivity is the ﬁrst direct evidence the C1 epitope resides in
DI. It is interesting, but not surprising, that H-4 mutations altered the
reactivity of MAb 2H3, which deﬁnes the A4 epitope on DII. It has been
shown fairly conclusively that the DII epitope A1 is located in the
fusion peptide, AA 98–110 (Crill and Chang, 2004; Huang et al., 2010).
Competitive binding assays have shown that the A1 and A4 epitopes
are not spatially related (Roehrig et al., 1998). Taken together, these
data suggest that the A1 and A4 epitopes are likely located on the
opposite ends of DII, placing A4 nearer DI and the H region. It should
be noted, however, that the mutations in the H region likely could
affect the conformation of the E protein and result in change of the
reactivity to certainMAbs that bind at a distal site from the H region of
the E protein homodimer. Therefore, we cannot conclude that any of
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affected MAbs.
In summary, we analyzed 11 residues within the hinge region of
DENV2, and identiﬁed nine of them (Q52, A54, E133, L135, F193,
G266, I270, T280, and G281) as important molecular determinants in
virus infection. None of these determinants has been examined in
DENV2, and four of them (E133, L135, G266, and G281) have never
been studied in any ﬂavivirus. In addition, our results also provide the
ﬁrst evidence that mutation at L135 can profoundly decrease virus
infection in whole mosquitoes. Although the region is highly
susceptible to mutations and some residues seem to be tolerant to
various substitutions, we have demonstrated particular properties of
the determinants and possible residue contacts or interactions that
are required to maintain the structure of the hinge for efﬁcient virus
infection. It has been proposed that the pocket structure of the
ﬂavivirus E protein hinge region would be an ideal target for
development of anti-viral therapeutic molecules to block the hinge
functions required for virus infection (Modis et al., 2003). Since the
region is highly susceptible to mutation, our study provides more
fundamental knowledge for evaluation of potential requirements for
successful anti-viral molecule design.
Materials and methods
Cell culture
Vero, HepG2, and K526 cells were cultured at 37 °C, and C6/36 cells
were cultured at 28 °C. Dulbecco's modiﬁed Eagle's medium (DMEM)
was used for Vero and C6/36 cells, Eagle's minimum essential medium
(EMEM) was used for culturing HepG2 cells (ATCC # HB-8065), and
RPMI-1640 medium was used for K562 cells (ATCC # CCL-243). All
growth media were supplemented with 10% fetal calf serum (FBS)
for cell growth, and with 5% FBS for virus-infected cultures. Medium
YE-LAH (0.165% lactalbumin hydrolysate, 0.033% yeast extract, Earl's
balanced salt solution, 25 mg of gentamycin sulfate, and 1 mg of
amphotericin B)with 5%FBSwas used for virus propagation and growth
studies in C6/36 cells.
Mutagenesis and recovery of mutant viruses
A DENV2 strain 16681 infectious cDNA plasmid, pD2/IC-30P-NBX,
derived from pD2/IC-30P-A (Kinney et al., 1997), was used to construct
all mutant clones as described previously (Huang et al., 2010). To derive
viruses from infectious clones, in vitro transcribed full-length RNAs
were transfected into Vero or C6/36 cells by electroporation as
previously described (Huang et al., 2010). Following 10–12 days (Vero
cells) or 14 days (C6/36 cells) of incubation, medium was harvested,
clariﬁed by centrifugation, adjusted to ﬁnal 20% FBS, and stored
at−70 °C for further studies. An aliquot was used to infect naïve cells
and incubated for another 12–14 days to make working virus stock.
Viability of the mutant virus was determined by indirect immunoﬂu-
orescence assays (IFA) of viral antigens in infected cells and RT-PCR
ampliﬁcation of viral genome in cell cultures. Full-length genomes of the
working seed viruses were sequenced to conﬁrm their genetic stability.
Viral RNA was extracted from seeds using QIAamp Viral RNA Kit
(Qiagen), and ampliﬁed using Titan One Tube RT-PCR Systems Kit
(Roche Applied Science, IN). The RT-PCR ampliﬁed fragments were
puriﬁed before sequencing.
Growth kinetics and temperature sensitivity of mutant viruses in cell
cultures
Twelve day growth curves were performed in Vero, HepG2, K562,
and C6/36 cells. Temperature sensitivity tests were performed in Vero
cell cultures at 28 or 37 °C for 12 days. Structural genes from day 12
samples of Vero and K562 growth curves as well as the Verotemperature sensitive experiment were sequenced to identify possible
compensatory and/or cell-adaptive mutations evolved during the
experiment. Cell cultures for growth kinetics and temperature sensi-
tivity determinations were infected in duplicate at a multiplicity of
infection (MOI) of 0.001 TCID50, and viral genomic equivalents were
measured by qRT-PCR (Butrapet et al., 2006). Samples with peak
genomic equivalent titers were measured for infectious virus by TCID50
in C6/36 cells (Huang et al., 2010).
Temperature shift assays
Four sets of freshly conﬂuent Vero cells in 12-well tissue culture
plates were infected with 0.5 ml of D2IC-30P-NBX or L135G virus at a
MOI of 0.5. Two sets of plates were incubated at 28 °C and the other
was kept at 37 °C for virus adsorption. After 2 h of virus absorption,
cells were washed 3 times with PBS, and incubated with 2 ml fresh
Iscove's DMEM medium. One set of the plates infected at 28 °C was
maintained at 28 °C, while the other set wasmoved to 37 °C. Similarly,
one set of plates infected at 37 °C was kept at 37 °C, but the other set
was shifted to 28 °C for incubation. At selected time points (2, 24, 48,
72, 120 and 168 h) post-infection, 300 μl of culture medium were
collected, and total intracellular RNA was extracted with Trizol
reagent (Invitrogen) after the cells were washed twice with PBS.
Triplicate samples were conducted for each time point. Quantities of
viral genome in the collected culture medium were analyzed by qRT-
PCR (Butrapet et al., 2006), and the intracellular negative-sense viral
RNA was measured by a 2-step RT-qPCR using designed tagged
primers to avoid false priming of positive-sense RNA as described
previously (Huang et al., 2010).
Aedes aegypti mosquito infection by intrathoracic inoculation
Ae. aegypti RexD strain laboratory mosquitoes originating from
Rexville, Puerto Rico, were reared from eggs andmaintained as adults at
28 °C, 80% relative humidity with a photocycle of 12 h light:12 h dark.
Intrathoracic (IT) inoculations were performed as described previously
(Huang et al., 2010). Working virus seeds were diluted to 1 × 105
TCID50/ml and adult female mosquitoes were IT inoculated with
0.3–0.5 μl of diluted virus. Injected mosquitoes were maintained for
7 days until head squasheswere performed. Virus antigenwas detected
in head tissues by IFA to determine infection rates. Head squash IFAs
were performed using ﬂavivirus E protein DII group-reactive mouse
MAb 4G2 as described previously (Brackney et al., 2008). Each IT
injection experiment was repeated three times for a total of 81–143
mosquitoes for each virus. Head infectivity rates were determined by
dividing thenumber of virus antigen-positivehead squashes by the total
number analyzed. To verify that no compensatorymutations developed
in L135G infected mosquitoes, viral RNA was extracted from the saved
body of a mosquito that was positive for virus antigen via head squash
IFA, and the entire E gene was sequenced.
Antigenic characterization of mutant E proteins
E protein reactivity of a panel of DENV and ﬂavivirusMAbs (Roehrig
et al., 1998), including 1B4C-2 (C1 epitope, in E protein DI), 4G2 and
6B6C-1(A1 epitope, DII), 2H3 (A4 epitope, DII), 1B7-5 (A5 epitope, DII),
3H5 (B1 epitope, DIII), 9A3D-8 (B2 epitope, DIII), and 1A1D-2 (B4
epitope, DIII), was compared to reactivitywithwt D2IC-30P-NBX by IFA
with acetone-ﬁxed virus-infected C6/36 cells (Huang et al., 2010). In
addition, epitope expression of mutant L135G E protein at 28 and 37 °C
was compared inVero cells. For this analysis, duplicate Vero cell cultures
were infectedwithmutantL135Gat28 °C for 2 h.Afterwashing the cells
3 times with PBS, fresh medium was added, and one ﬂask of infected
cellswas incubated at28 °Cand theother at 37 °C. Cells in the37 °Cﬂask
were harvested after 24 h of infection, and the cells kept at 28 °C were
harvested 4 days later. Infected cells were gently scraped off after PBS
127S. Butrapet et al. / Virology 413 (2011) 118–127wash, dropped on poly-L-lysine coated slides, air dried, and ﬁxed in
cold acetone. IFA with D2-NGC polyclonal antibody (mouse hyperim-
mune ascitic ﬂuid) was included as a control to normalize different
activities (within 2-fold) due to different amounts of intracellular E
proteins expressed at the two temperatures (Table 4). Results were
averages of the endpoint dilution ofMAbs from2 separate experiments.
Fusion from within (FFWI) assay
Fusion activity was measured by quantitating cell–cell fusion of
virus-infected C6/36 cells as previously described (Guirakhoo et al.,
1993; Huang et al., 2010). Brieﬂy, C6/36 cells in 24-well plates were
infected atMOI of 0.1 andmaintained in pH 7.7mediumat 28 °C. At day
7 post-infection when almost all cells would be infected, cell medium
was replaced by fusion medium buffered between pH 5.5 and 6.8, and
incubated for 2 h at 28 °C. Cells were returned to pH 7.7 medium for
additional 24 h incubation and stained with Hema-3 quick stain
(Fig. 4B). Numbers of cells and nuclei were counted and fusion index
(FI) was calculated as previously reported (Huang et al., 2010). Fusion
curves were plotted as mean FI from at least 2 experiments for each pH
(Fig. 4A), and fusion pH threshold rangewas shown as FI≥0.5 (Table 1).
Fusion activity at pH5.5 was calculated to determine overall fusion
capacity of eachmutant (Table 1). Triplicatemock-infected cell controls
and wt 30P-NBX controls were included in each experimental plate for
calibration of the fusion activity at pH 5.5. Fusion activity at pH 5.5=
(mutant FI – mock cell FI) / (30P-NBX FI – mock cell FI). The standard
deviation was calculated from triplicate samples of each virus.
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